Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Washington, District of Columbia 20037


Purpose:

To identify patients that are at risk of heart damage after receiving chemotherapy (adriamycin).


Study summary:

To identify patients at risk of development of heart damage after receiving chemotherapy by obtaining the genetic profile of those who show: elevation of troponin, left ventricular systolic and diastolic dysfunction, and pro-oxidant stress markers.


Criteria:

Inclusion Criteria: - undergoing anthracycline and/or trastuzumab therapy for the first time Exclusion Criteria: - abnormal ventricular ejection fraction - past history of, or active cardiac disease including: MI, CHF, angina, arrhythmia requiring medication, valvular disease, uncontrolled systemic hypertension


NCT ID:

NCT00636844


Primary Contact:

Principal Investigator
Jannet Lewis, MD
George Washington University


Backup Contact:

N/A


Location Contact:

Washington, District of Columbia 20037
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 20, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.